Future SciBars
Information about Upcoming SciBars
Microbes and antiobiotic resistance
Monday 10 June 2013, 6:30pm
Speaker: Joyce Johnson
Our very own Joyce Johnson will tell us more about the potential threat to public health from antibiotic-resistant bacteria
Talk starts at 6.30pm, the Vale Inn, Adlington Road, Bollington. Arrive early to get a good seat. All welcome, no charge.
Sleep!
Monday 8 July 2013, 6:30pm
Speaker: Penny Lewis
Dr Penny Lewis, a lecturer at Manchester University in the Neuroscience of Aphasia Research Unit will tell us about her research into sleep and the techniques used in the Sleep and Memory Lab to study sleep.
More details to follow but we are intrigued by the Sleep lab’s“New two-bed sleep lab complete with two full N7000 polysomnography (PSG) systems”.
As usual, event starts at 6.30pm, the Vale Inn, Adlington Road. Arrive early to get a good seat. All welcome, no charge.
Starchaser – The Sky Is Not The Limit!
Monday 9 September 2013, 6:30pm
Speaker: Steve Bennett
British Space Company Starchaser Industries are building the rockets and related hardware that is set open the frontier of space for everyone. Space Tourism is just around the corner, a revolutionary multi-billion pound industry in which Starchaser is set to take centre stage. Starchaser founder Steve Bennett talks about the project from its humble beginnings, through the high and low points to where the realisation of his childhood dream will ultimately lead.
Event starts 6.30pm at the Vale Inn, Adlington Road. As usual, arrive early to get a good seat. All are welcome.



Brain Imaging and Mental Health
Monday 14 October 2013, 6:30pm
Speaker: Rebecca Elliot
Rebecca Elliot of Manchester University will tell us about how she uses brain imaging techniques (particularly functional magnetic resonance imaging, fMRI) to explore the neurobiological basis of emotional, motivational and social processes, particularly in the context of mental health.
Microbiology (title TBD)
Monday 11 November 2013, 6:30pm
Speaker: Aileen Allsop
Talk by Aileen Allsop, formerly head of infection at AstraZeneca in Macclesfield.